BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 37029872)

  • 1. Epidemiology and prognostic factors of 114 patients with mycosis fungoides in a Moroccan cohort: a 29-year review.
    Titou H; Bouhamidi A
    Clin Exp Med; 2023 Nov; 23(7):3751-3758. PubMed ID: 37029872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics and outcomes of 727 patients with mycosis fungoides and Sézary syndrome from a Brazilian cohort.
    Miyashiro D; Sanches JA
    Int J Dermatol; 2022 Apr; 61(4):442-454. PubMed ID: 34435672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics and long-term outcome of 223 patients with mycosis fungoides at a single tertiary center in Korea: A 29-year review.
    Suh KS; Jang MS; Jung JH; Kwon DI; Seong SH; Lee KH; Park JB
    J Am Acad Dermatol; 2022 Jun; 86(6):1275-1284. PubMed ID: 34197872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical characteristics, risk factors and long-term outcome of 114 patients with folliculotropic mycosis fungoides.
    Wieser I; Wang C; Alberti-Violetti S; Lyons G; Tran C; Talpur R; Duvic M
    Arch Dermatol Res; 2017 Aug; 309(6):453-459. PubMed ID: 28516243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Juvenile mycosis fungoides: cutaneous T-cell lymphoma with frequent follicular involvement.
    Hodak E; Amitay-Laish I; Feinmesser M; Davidovici B; David M; Zvulunov A; Pavlotsky F; Yaniv I; Avrahami G; Ben-Amitai D
    J Am Acad Dermatol; 2014 Jun; 70(6):993-1001. PubMed ID: 24629999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Updated review on prognostic factors in mycosis fungoides and new skin lymphoma trials.
    Farabi B; Seminario-Vidal L; Jamgochian M; Akay BN; Atak MF; Rao BK; Karagaiah P; Grabbe S; Goldust M
    J Cosmet Dermatol; 2022 Jul; 21(7):2742-2748. PubMed ID: 34687485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycosis Fungoides in Puerto Rico: A 15-year Follow-up Retrospective Study.
    Arias-Berrios GE; Falto-Aizpurua L; Figueroa-Guzmán L
    P R Health Sci J; 2020 Dec; 39(4):306-310. PubMed ID: 33320459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The different faces of mycosis fungoides: results of a single-center study.
    Sidiropoulou P; Nikolaou V; Marinos L; Voudouri D; Komini E; Economidi A; Rigopoulos D; Stratigos A
    Int J Dermatol; 2020 Mar; 59(3):314-320. PubMed ID: 31782525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival outcomes and prognostic factors in mycosis fungoides/Sézary syndrome: validation of the revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer staging proposal.
    Agar NS; Wedgeworth E; Crichton S; Mitchell TJ; Cox M; Ferreira S; Robson A; Calonje E; Stefanato CM; Wain EM; Wilkins B; Fields PA; Dean A; Webb K; Scarisbrick J; Morris S; Whittaker SJ
    J Clin Oncol; 2010 Nov; 28(31):4730-9. PubMed ID: 20855822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular staging of lymph nodes from 60 patients with mycosis fungoides and Sézary syndrome: correlation with histopathology and outcome suggests prognostic relevance in mycosis fungoides.
    Fraser-Andrews EA; Mitchell T; Ferreira S; Seed PT; Russell-Jones R; Calonje E; Whittaker SJ
    Br J Dermatol; 2006 Oct; 155(4):756-62. PubMed ID: 16965425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperpigmented mycosis fungoides: a retrospective and comparative analysis with other subtypes of mycosis fungoides.
    Jung JM; Lee MY; Won CH; Chang SE; Lee MW; Lee WJ
    Leuk Lymphoma; 2022 Jul; 63(7):1598-1606. PubMed ID: 35201905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transformation of Mycosis Fungoides/Sezary Syndrome: Clinical Characteristics and Prognosis.
    Vural S; Akay BN; Botsalı A; Atilla E; Parlak N; Okçu Heper A; Şanlı H
    Turk J Haematol; 2018 Mar; 35(1):35-41. PubMed ID: 28533196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon alfa-2a maintenance after salvage autologous stem cell transplantation in atypical mycosis fungoides with central nervous system involvement.
    Doerschner M; Pekar-Lukacs A; Messerli-Odermatt O; Dommann-Scherrer C; Rütti M; Müller AM; Nair G; Kamarachev J; Kerl K; Beer M; Messerli M; Frauenknecht K; Haralambieva E; Hoetzenecker W; French LE; Guenova E
    Br J Dermatol; 2019 Dec; 181(6):1296-1302. PubMed ID: 30565216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The PROCLIPI international registry of early-stage mycosis fungoides identifies substantial diagnostic delay in most patients.
    Scarisbrick JJ; Quaglino P; Prince HM; Papadavid E; Hodak E; Bagot M; Servitje O; Berti E; Ortiz-Romero P; Stadler R; Patsatsi A; Knobler R; Guenova E; Child F; Whittaker S; Nikolaou V; Tomasini C; Amitay I; Prag Naveh H; Ram-Wolff C; Battistella M; Alberti-Violetti S; Stranzenbach R; Gargallo V; Muniesa C; Koletsa T; Jonak C; Porkert S; Mitteldorf C; Estrach T; Combalia A; Marschalko M; Csomor J; Szepesi A; Cozzio A; Dummer R; Pimpinelli N; Grandi V; Beylot-Barry M; Pham-Ledard A; Wobser M; Geissinger E; Wehkamp U; Weichenthal M; Cowan R; Parry E; Harris J; Wachsmuth R; Turner D; Bates A; Healy E; Trautinger F; Latzka J; Yoo J; Vydianath B; Amel-Kashipaz R; Marinos L; Oikonomidi A; Stratigos A; Vignon-Pennamen MD; Battistella M; Climent F; Gonzalez-Barca E; Georgiou E; Senetta R; Zinzani P; Vakeva L; Ranki A; Busschots AM; Hauben E; Bervoets A; Woei-A-Jin FJSH; Matin R; Collins G; Weatherhead S; Frew J; Bayne M; Dunnill G; McKay P; Arumainathan A; Azurdia R; Benstead K; Twigger R; Rieger K; Brown R; Sanches JA; Miyashiro D; Akilov O; McCann S; Sahi H; Damasco FM; Querfeld C; Folkes A; Bur C; Klemke CD; Enz P; Pujol R; Quint K; Geskin L; Hong E; Evison F; Vermeer M; Cerroni L; Kempf W; Kim Y; Willemze R
    Br J Dermatol; 2019 Aug; 181(2):350-357. PubMed ID: 30267549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The diagnosis, staging, and treatment options for mycosis fungoides.
    Keehn CA; Belongie IP; Shistik G; Fenske NA; Glass LF
    Cancer Control; 2007 Apr; 14(2):102-11. PubMed ID: 17387295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poikilodermatous mycosis fungoides: a study of its clinicopathological, immunophenotypic, and prognostic features.
    Abbott RA; Sahni D; Robson A; Agar N; Whittaker S; Scarisbrick JJ
    J Am Acad Dermatol; 2011 Aug; 65(2):313-319. PubMed ID: 21529998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Outcome and Prognosis of Young Patients with Mycosis Fungoides.
    Virmani P; Levin L; Myskowski PL; Flores E; Marchetti MA; Lucas AS; Pulitzer M; Horwitz S; Trippett T; Moskowitz A; Querfeld C
    Pediatr Dermatol; 2017 Sep; 34(5):547-553. PubMed ID: 28804919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycosis fungoides in pediatric patients: Clinical features, diagnostic challenges, and advances in therapeutic management.
    Wu JH; Cohen BA; Sweren RJ
    Pediatr Dermatol; 2020 Jan; 37(1):18-28. PubMed ID: 31630432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folliculotropic mycosis fungoides: Clinical characteristics, treatments, and long-term outcomes of 53 patients in a tertiary hospital.
    Kalay Yildizhan I; Sanli H; Akay BN; Uzundere C; Okcu Heper A
    Dermatol Ther; 2020 Jul; 33(4):e13585. PubMed ID: 32410323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical heterogeneity of poikilodermatous mycosis fungoides: A retrospective study of 12 cases].
    Rohmer E; Mitcov M; Cribier B; Lipsker D; Lenormand C
    Ann Dermatol Venereol; 2020; 147(6-7):418-428. PubMed ID: 32229035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.